X

pharmaceuticals

Sequent Scientific Ltd Q2FY24; 2% rise in Revenue

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides…

Divi’s Laboratories Ltd Q2 FY24 Earnings Conference Call Insights

Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q2 FY24 Earnings Concall Business Overview Anticipating growth opportunities in contrast media, sartans,…

Ajanta Pharma Ltd Q2FY24; 24% rise in Profits

Ajanta Pharma is primarily engaged in development, manufacturing and marketing of speciality pharmaceutical quality finished dosages. Financial Results: Ajanta Pharma…

TTK Healthcare Ltd Q2FY24; 60% rise in Profits

TTK Healthcare Ltd is engaged in the business of Pharmaceuticals, Consumer Products, Medical Devices, Protective Devices and Foods. It is…

Sun Pharmaceuticals Industries Ltd Q2FY24; 6% rise in Profits

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and…

Unichem Laboratories Ltd Q2FY24; 26% rise in Revenue

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas. Financial Results: Unichem Laboratories Ltd…

Dr Reddys Laboratories Ltd Q2FY24; 33% rise in Profits

Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active…

Cipla Ltd Q2FY24; 45% rise in Profits

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues…

Strides Pharma Science Ltd Q2FY24; 11% rise in Revenue

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are…

Cipla Limited Q2 FY24 Earnings Conference Call Insights

Key highlights from Cipla Limited (CIPLA) Q2 FY24 Earnings Concall Financial Performance Highest ever quarterly revenue of INR6,678 crores, up…